Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Brand Name :
Rozerem
Synonyms :
ramelteon
Class :
Sedative/Hypnotics; Melatonin Receptor Agonists
Dosage Forms & Strengths
Tablet
8mg
8 mg orally taken 30 minutes before bed
The Maximum Dose per day is 8 mg
Note:
Avoid taking this medication with or right after a high-fat meal
Safety and efficacy not established
Refer to adult dosing
ramelteon: they may enhance the serum concentration of CYP1A2 Inhibitors
ramelteon: they may enhance the serum concentration of CYP1A2 Inhibitors
ramelteon: they may enhance the serum concentration of CYP1A2 Inhibitors
ramelteon: they may enhance the serum concentration of CYP1A2 Inhibitors
ramelteon: they may enhance the serum concentration of CYP1A2 Inhibitors
CYP3A strong enhancers of the small intestine may reduce the bioavailability of ramelteon 
It may enhance sedation when combined with a shepherd's purse
it may diminish the excretion rate when combined with gadofosveset, resulting in an enhanced serum level
It may diminish the metabolism when combined with Melatonin
It may diminish the metabolism when combined with Melatonin
It may diminish the metabolism when combined with Melatonin
It may diminish the metabolism when combined with Melatonin
It may diminish the metabolism when combined with Melatonin
It may enhance the risk of adverse effects when combined with Decongestants
It may enhance the risk of adverse effects when combined with Decongestants
It may enhance the risk of adverse effects when combined with Decongestants
It may enhance the risk of adverse effects when combined with Decongestants
It may enhance the risk of adverse effects when combined with Decongestants
It may enhance the risk of adverse reactions when combined with P2Y12 inhibitors
It may enhance the risk of adverse reactions when combined with P2Y12 inhibitors
Actions and Spectrum:
Actions:
Spectrum:
Frequency defined
1-10%
Fatigue
Somnolence
Headache
Dizziness
Nausea
Dysgeusia
Frequency Not Defined
Hallucinations
Worsening of insomnia
Depression
Black Box Warning
ramelteon used to treat insomnia, carries a black box warning regarding the potential for increased risk of depression and suicidal thoughts.
Contraindication/Caution:
Contraindication:
Caution:
ramelteon should be used with caution in individuals taking medications that may interact with it, such as fluvoxamine, ketoconazole, or rifampin. Consult with a healthcare professional before taking any new medications while taking ramelteon.
Pregnancy warnings:   
US FDA pregnancy category: C
Lactation:
Excreted into human milk is unknown
Pregnancy Categories:     
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester. 
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.  
Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.  
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.  
Category N: There is no data available for the drug under this category
Pharmacology:
ramelteon is a medication used for the treatment of insomnia. It is a melatonin receptor agonist, which means it works by mimicking the effects of the hormone melatonin in the body. Melatonin is a hormone that regulates the sleep-wake cycle, and its levels naturally increase in the evening to promote sleep.
Pharmacodynamics:
ramelteon binds to the melatonin receptors in the brain, specifically the MT1 and MT2 receptors. By binding to these receptors, it helps to regulate the sleep-wake cycle and promote sleep. It also has a lower binding affinity for other receptors in the brain, such as the serotonin and GABA receptors, which helps to minimize the potential for side effects.
Pharmacokinetics:
Absorption
ramelteon is well absorbed after oral administration, with an absorption rate of 84%. However, due to extensive first-pass metabolism, its bioavailability is relatively low at 1.8%
Distribution
Once absorbed, ramelteon is highly protein-bound, with 82% of the medication being bound to proteins in the blood. This can affect its overall activity and distribution within the body
Metabolism
ramelteon is primarily metabolized by the liver enzyme CYP1A2. This enzyme is responsible for breaking down the medication and reducing its active levels in the body
Elimination and excretion
Most of the medication is excreted via the urine, with 84% of the dose being eliminated in this way. A small amount (4%) is eliminated in the feces. The elimination half-life is approximately 1 hour, which means it is rapidly metabolized and eliminated from the body
Administration:
Oral Administration
It should be taken orally, usually 30 minutes before bedtime. The recommended starting dose is 8 mg per day, which can be increased to a maximum of 16 mg per day if needed.
It is important to take ramelteon exactly as prescribed by your healthcare provider. Do not take more or less than the recommended dose, and do not take it for longer than prescribed.
Do not drink alcohol while taking Ramelteon, as it can increase the risk of side effects. Also, do not take other sedatives or sleep medications while taking Ramelteon, as it can cause excessive drowsiness and other serious side effects.
If you miss a dose of Ramelteon, do not take a double dose to make up for it. Just take your next scheduled dose at the usual time.
If you experience any side effects while taking Ramelteon, such as drowsiness, dizziness, or nausea, contact your healthcare provider immediately.
It is important to talk to your healthcare provider about any medical conditions you have or any other medications or supplements you are taking before starting treatment with ramelteon.
Patient information leaflet
Generic Name: ramelteon
Why do we use ramelteon?
ramelteon is used to treat insomnia, which is a sleep disorder characterized by difficulty falling asleep or staying asleep. It works by binding to a specific receptor in the brain called the melatonin receptor, which helps regulate the body’s sleep-wake cycle. By binding to this receptor, ramelteon helps promote feelings of sleepiness and relaxation, making it easier for people with insomnia to fall asleep and stay asleep. ramelteon is typically used for short-term treatment of insomnia and is not recommended for long-term use.